vs
Side-by-side financial comparison of AlTi Global, Inc. (ALTI) and PUMA BIOTECHNOLOGY, INC. (PBYI). Click either name above to swap in a different company.
AlTi Global, Inc. is the larger business by last-quarter revenue ($86.6M vs $75.5M, roughly 1.1× PUMA BIOTECHNOLOGY, INC.). On growth, AlTi Global, Inc. posted the faster year-over-year revenue change (87.0% vs 27.7%). PUMA BIOTECHNOLOGY, INC. produced more free cash flow last quarter ($14.4M vs $-52.2M). Over the past eight quarters, PUMA BIOTECHNOLOGY, INC.'s revenue compounded faster (31.3% CAGR vs 30.6%).
Cristal Global is the world's second-largest producer of titanium dioxide and a leading producer of titanium chemicals. It was formed when The National Titanium Dioxide Company Ltd. combined with Millennium Chemicals. The headquarters are in Jeddah, Saudi Arabia. It is a significant shareholder in Bemax, the world’s 5th largest TiO2 feedstock producer.
Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.
ALTI vs PBYI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $86.6M | $75.5M |
| Net Profit | $-13.1M | — |
| Gross Margin | — | 69.3% |
| Operating Margin | -2.1% | 22.7% |
| Net Margin | -15.1% | — |
| Revenue YoY | 87.0% | 27.7% |
| Net Profit YoY | 75.6% | — |
| EPS (diluted) | — | $0.26 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $86.6M | $75.5M | ||
| Q3 25 | $57.2M | $54.5M | ||
| Q2 25 | $53.1M | $52.4M | ||
| Q1 25 | $58.0M | $46.0M | ||
| Q4 24 | $46.3M | $59.1M | ||
| Q3 24 | $51.8M | $80.5M | ||
| Q2 24 | $49.5M | $47.1M | ||
| Q1 24 | $50.8M | $43.8M |
| Q4 25 | $-13.1M | — | ||
| Q3 25 | $-84.1M | $8.8M | ||
| Q2 25 | $-24.4M | $5.9M | ||
| Q1 25 | $1.9M | $3.0M | ||
| Q4 24 | $-53.8M | — | ||
| Q3 24 | $-72.5M | $20.3M | ||
| Q2 24 | $-6.4M | $-4.5M | ||
| Q1 24 | $29.7M | $-4.8M |
| Q4 25 | — | 69.3% | ||
| Q3 25 | — | 77.7% | ||
| Q2 25 | — | 76.5% | ||
| Q1 25 | — | 77.1% | ||
| Q4 24 | — | 76.4% | ||
| Q3 24 | — | 63.9% | ||
| Q2 24 | — | 77.4% | ||
| Q1 24 | — | 75.5% |
| Q4 25 | -2.1% | 22.7% | ||
| Q3 25 | -49.8% | 17.6% | ||
| Q2 25 | -56.7% | 12.7% | ||
| Q1 25 | -23.3% | 8.7% | ||
| Q4 24 | -42.7% | 22.6% | ||
| Q3 24 | -18.4% | 27.4% | ||
| Q2 24 | -30.2% | -4.6% | ||
| Q1 24 | -28.9% | -5.3% |
| Q4 25 | -15.1% | — | ||
| Q3 25 | -147.0% | 16.2% | ||
| Q2 25 | -45.9% | 11.2% | ||
| Q1 25 | 3.3% | 6.5% | ||
| Q4 24 | -116.1% | — | ||
| Q3 24 | -140.0% | 25.2% | ||
| Q2 24 | -12.9% | -9.6% | ||
| Q1 24 | 58.4% | -11.0% |
| Q4 25 | — | $0.26 | ||
| Q3 25 | — | $0.17 | ||
| Q2 25 | $-0.33 | $0.12 | ||
| Q1 25 | $-0.04 | $0.06 | ||
| Q4 24 | $-0.71 | $0.40 | ||
| Q3 24 | $-0.88 | $0.41 | ||
| Q2 24 | $-0.18 | $-0.09 | ||
| Q1 24 | $0.18 | $-0.10 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $41.2M | $97.5M |
| Total DebtLower is stronger | $883.0K | $22.7M |
| Stockholders' EquityBook value | $600.1M | $130.3M |
| Total Assets | $1.2B | $216.3M |
| Debt / EquityLower = less leverage | 0.00× | 0.17× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $41.2M | $97.5M | ||
| Q3 25 | $35.8M | $94.4M | ||
| Q2 25 | $42.4M | $96.0M | ||
| Q1 25 | $52.8M | $93.2M | ||
| Q4 24 | $64.4M | $101.0M | ||
| Q3 24 | $220.6M | $96.7M | ||
| Q2 24 | $60.0M | $96.8M | ||
| Q1 24 | $134.2M | $107.2M |
| Q4 25 | $883.0K | $22.7M | ||
| Q3 25 | $586.0K | $34.0M | ||
| Q2 25 | $673.0K | $45.3M | ||
| Q1 25 | — | $56.7M | ||
| Q4 24 | $0 | $68.0M | ||
| Q3 24 | $128.4M | $79.3M | ||
| Q2 24 | $164.0M | $90.7M | ||
| Q1 24 | $183.7M | $102.0M |
| Q4 25 | $600.1M | $130.3M | ||
| Q3 25 | $607.2M | $115.3M | ||
| Q2 25 | $685.4M | $104.7M | ||
| Q1 25 | $665.2M | $97.1M | ||
| Q4 24 | $658.4M | $92.1M | ||
| Q3 24 | $707.0M | $71.1M | ||
| Q2 24 | $540.2M | $48.5M | ||
| Q1 24 | $510.9M | $51.0M |
| Q4 25 | $1.2B | $216.3M | ||
| Q3 25 | $1.2B | $202.9M | ||
| Q2 25 | $1.2B | $194.9M | ||
| Q1 25 | $1.2B | $196.2M | ||
| Q4 24 | $1.3B | $213.3M | ||
| Q3 24 | $1.4B | $220.7M | ||
| Q2 24 | $1.3B | $205.0M | ||
| Q1 24 | $1.3B | $214.1M |
| Q4 25 | 0.00× | 0.17× | ||
| Q3 25 | 0.00× | 0.30× | ||
| Q2 25 | 0.00× | 0.43× | ||
| Q1 25 | — | 0.58× | ||
| Q4 24 | 0.00× | 0.74× | ||
| Q3 24 | 0.18× | 1.12× | ||
| Q2 24 | 0.30× | 1.87× | ||
| Q1 24 | 0.36× | 2.00× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-51.4M | $14.4M |
| Free Cash FlowOCF − Capex | $-52.2M | $14.4M |
| FCF MarginFCF / Revenue | -60.3% | 19.1% |
| Capex IntensityCapex / Revenue | 0.9% | 0.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $41.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-51.4M | $14.4M | ||
| Q3 25 | $-53.5M | $9.7M | ||
| Q2 25 | $-19.9M | $14.1M | ||
| Q1 25 | $-30.2M | $3.6M | ||
| Q4 24 | $-50.7M | $15.6M | ||
| Q3 24 | $-4.9M | $11.0M | ||
| Q2 24 | $-30.2M | $1.0M | ||
| Q1 24 | $-15.5M | $11.2M |
| Q4 25 | $-52.2M | $14.4M | ||
| Q3 25 | — | $9.7M | ||
| Q2 25 | $-20.0M | $14.1M | ||
| Q1 25 | $-31.0M | $3.6M | ||
| Q4 24 | $-58.2M | $15.6M | ||
| Q3 24 | $-9.4M | $11.0M | ||
| Q2 24 | $-31.2M | $1.0M | ||
| Q1 24 | $-15.7M | — |
| Q4 25 | -60.3% | 19.1% | ||
| Q3 25 | — | 17.7% | ||
| Q2 25 | -37.6% | 26.8% | ||
| Q1 25 | -53.4% | 7.7% | ||
| Q4 24 | -125.7% | 26.4% | ||
| Q3 24 | -18.2% | 13.7% | ||
| Q2 24 | -63.2% | 2.1% | ||
| Q1 24 | -30.9% | — |
| Q4 25 | 0.9% | 0.0% | ||
| Q3 25 | 0.0% | 0.0% | ||
| Q2 25 | 0.0% | 0.0% | ||
| Q1 25 | 1.3% | 0.1% | ||
| Q4 24 | 16.3% | 0.0% | ||
| Q3 24 | 8.7% | 0.0% | ||
| Q2 24 | 2.2% | 0.0% | ||
| Q1 24 | 0.4% | 0.0% |
| Q4 25 | — | — | ||
| Q3 25 | — | 1.10× | ||
| Q2 25 | — | 2.41× | ||
| Q1 25 | -15.80× | 1.21× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.54× | ||
| Q2 24 | — | — | ||
| Q1 24 | -0.52× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ALTI
| Management Advisory Fees | $51.1M | 59% |
| Other | $32.7M | 38% |
| Distributions From Investments | $2.9M | 3% |
PBYI
Segment breakdown not available.
